NPI registry status
Active
2026 NPPES data Dermatology Physician NPI 1942201702 MD
Verify on CMS → Andrew Calciano, MD
Dermatology Physician in Santa Cruz, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 560 beneficiaries · Dermatology Physician avg: 799
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.6/100
▼ 4 pts below national avg 83.5 · Above neutral
Industry payments
$146.04
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Andrew Calciano, MD reported a CMS MIPS final score of 79.6/100 - below the 83.5 national average - and filed 1,381 Medicare Part D claims in 2024.
- 79.6/100
- MIPS score · -4 vs avg
- 1K
- Part D claims, 2024
- 96%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Andrew Calciano, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1942201702), first enumerated 08/02/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,381 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 79.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$146.04 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Andrew Calciano, MD's individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1942201702 · Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-BELOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1942201702
- ENUM-LEGACY 2005
- TAX-MID 15K Dermatology Physician
- MIPS-BELOW 79.6/100
- RX-MID 1,381
- BOOK-LIGHT 2,004 in California
- PHOTO-FINISH Karen Harkaway, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Calciano · this …
Calciano · this provider
79.6 MIPS pts
- Hasnain Rangwala…
Hasnain Rangwala, PA-C
79.6 MIPS pts
- Carmen Berger, M…
Carmen Berger, MD
79.6 MIPS pts
- William Massenga…
William Massengale, MD
79.6 MIPS pts
- Karen Harkaway, …
Karen Harkaway, MD
79.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Andrew Calciano, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
80 ≥ 26th percentile 26% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Andrew Calciano, MD sits
This provider among dermatology physician peers
Across the 5,700 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Andrew Calciano, MD writes more Part D claims than 84% of them and scores higher on MIPS quality than 29% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is Andrew Calciano, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Andrew Calciano, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Andrew Calciano, MD?
Near national averagePrimary specialty
Dermatology Physician
Medicare Part D claims
1,381 73% vs specialty avg
MIPS final score
79.6/100 3.9 pts vs avg
Specialty distribution in California
How Dermatology Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Andrew Calciano, MD's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 79.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1942201702 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/02/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
79.5841
Final Score
Measured-score avg: 83.5
93.4256
Quality
40.188
Cost
98
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Andrew Calciano, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Forefront Dermatology - Pacific, P.C.
Santa Cruz, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Andrew Calciano, MD. Source: openpaymentsdata.cms.gov.
Total received
$146
Largest payer
Regeneron Healthcare Solutions, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Andrew Calciano, MD. To verify Andrew Calciano, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Andrew Calciano, MD - brand share 4.0%
Dermatology Physician average
4% brand-name claims vs 96% generic, on 1,381 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,381
Total Claims
$314K
Total Drug Cost
560
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,539.633
- Total Day Supply
- 40,215
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $272K
- Generic Drug Cost
- $42K
- Opioid Claims
- 21 (1.5% rate)
- Antibiotic Claims
- 117
Patient Demographics
- Average Patient Age
- 75.2 years
- Avg HCC Risk Score
- 0.92
- Gender Split
- 48% female / 52% male
- Age Distribution
- <65: 21, 65-74: 258, 75-84: 210, 85+: 71
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Andrew Calciano, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ketoconazole
Ketoconazole
219 claims
- Betamethasone Dipr…
Betamethasone Diprop Augmented
158 claims
- Triamcinolone Acet…
Triamcinolone Acetonide
146 claims
- Hydrocortisone
Hydrocortisone
102 claims
- Cephalexin 66
Cephalexin
66 claims
- Metronidazole 65
Metronidazole
65 claims
- Mupirocin 48
Mupirocin
48 claims
- Fluorouracil 45
Fluorouracil
45 claims
| Drug | Claims |
|---|---|
| Ketoconazole | 219 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 158 |
| Triamcinolone Acetonide | 146 |
| Hydrocortisone | 102 |
| Cephalexin | 66 |
| Metronidazole | 65 |
| Mupirocin | 48 |
| Fluorouracil | 45 |
| Valacyclovir Valacyclovir Hcl | 44 |
| Fluticasone Propionate | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Andrew Calciano, MD fits within the Dermatology Physician landscape nationally.
15,011
Dermatology Physician Providers in US
53
States with Dermatology Physician
799
Avg Claims per Provider
Andrew Calciano, MD's 1,381 claims are above the specialty average of 799.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Calciano, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (79.6 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Calciano.
One of 2,004 Dermatology Physician providers enrolled in California, 5 are shown here.
Dr. Sumaira Aasi
MD
Stanford, CA
Dr. Christopher Abbott
M.D.
San Diego, CA
Dr. Eman Abdallah
D.O.
Los Angeles, CA
Dr. Farah Abdulla
MD
Duarte, CA
Dr. Sayyida Abdus-Salaam
M.D.
Daly City, CA
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Andrew Calciano, MD's specialty? ▼
Andrew Calciano, MD specializes in Dermatology Physician and practices in Santa Cruz, California. Credentials: MD.
How much does Andrew Calciano, MD prescribe under Medicare Part D? ▼
In 2024, Andrew Calciano, MD wrote 1,381 Medicare Part D claims totaling $314K in drug costs for 560 beneficiaries.
What is Andrew Calciano, MD's Medicare quality score? ▼
Andrew Calciano, MD has a CMS MIPS Final Score of 79.6/100 (Quality: 93.4, Cost: 40.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Andrew Calciano, MD located? ▼
Andrew Calciano, MD is located at 1661 SOQUEL DR STE E, Santa Cruz, CA, 95065. Phone: (831) 476-2444.
What is Andrew Calciano, MD's NPI number? ▼
Andrew Calciano, MD's National Provider Identifier (NPI) is 1942201702, issued on 08/02/2005.
Does Andrew Calciano, MD prescribe more brand-name or generic drugs? ▼
Andrew Calciano, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $272K in brand drug costs.
Does Andrew Calciano, MD prescribe opioids? ▼
Yes, Andrew Calciano, MD had 21 opioid claims in 2024 with an opioid prescribing rate of 1.5%.
How many Dermatology Physician providers are there in the US? ▼
There are 15,011 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 799 Medicare Part D claims per year.
What drugs does Andrew Calciano, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Andrew Calciano, MD's most frequently prescribed drugs include Ketoconazole, Betamethasone Diprop Augmented, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Andrew Calciano, MD accept Medicare? ▼
Andrew Calciano, MD appears in CMS Medicare data with 1,381 Part D claims and 560 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Andrew Calciano, MD's credentials? ▼
Andrew Calciano, MD's NPI is 1942201702 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.